oseltamivir has been researched along with Cross Infection in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (35.00) | 29.6817 |
2010's | 24 (60.00) | 24.3611 |
2020's | 2 (5.00) | 2.80 |
Authors | Studies |
---|---|
Blyth, CC; Cheng, AC; Macartney, KK; McRae, JE; Quinn, HE; Wood, NJ | 1 |
Fujita, J; Fujita, M; Inafuku, Y; Matsumoto, H; Toyama, J | 1 |
Jiang, D; Loeppky, C; Singh, D; Van Caeseele, P | 1 |
Bonfanti, C; Cattaneo, C; Corbellini, S; Perandin, F; Piccinelli, G; Pollara, CP; Rossi, G; Tomasi, DD | 1 |
Cabral, E; Carratalá, J; Cordero, E; Cruzado, JM; Delgado, JF; Gavaldá, J; Gómez-Bravo, MÁ; López-Medrano, F; Marcos, MÁ; Pérez-Romero, P; Sabé, N | 2 |
Jurek, T; Kuchar, E; Rorat, M; Szenborn, L | 1 |
Bhadelia, N; Furuya, EY; Jia, H; McCarthy, JW; Saiman, L; Sonti, R; Vorenkamp, J | 1 |
Adams, W; Gregg, K; Humar, A; Huprikar, S; Kumar, D; Levi, M; Mossad, S; Patel, G; Razonable, RR; Reid, G; Shoham, S | 1 |
de Briel, D; Heller, R; Martin, A; Martinot, M; Mohseni-Zadeh, M; Mothes, A; Sagot, E; Souply, L | 1 |
Ak, Ö; Alan, S; Aslan, T; Badur, S; Balkan, II; Benzonana, N; Ceylan, B; Ciblak, M; Dokucu, AI; Engin, D; Eraksoy, H; Ergönül, Ö; Fincancı, M; Gencer, S; Göktaş, P; Gulhan, E; Gündüz, A; Inan, A; Kantürk, A; Midilli, K; Nazlıcan, O; Öncül, O; Özer, S; Özgüneş, N; Ozyurt, M; Saltoğlu, N; Sargın, F; Şimşek, F; Uzun, N; Yazıcı, S; Yıldırmak, T | 1 |
Chan, JF; Chan, KH; Chan, WM; Chen, JH; Cheng, VC; Ho, PL; Lee, WM; Poon, RW; Tai, JW; To, KK; Wong, SC; Yuen, KY | 1 |
Cheng, VC; Ho, PL; Lee, WM; Sridhar, S; Yuen, KY | 1 |
Hibino, A; Kondo, H; Masaki, H; Saito, R; Saito, T; Sato, I; Takemae, N; Tanabe, Y; Zaraket, H | 1 |
Collins, JT; Kennedy, GA; Subramoniapillai, E; Yue, MC | 1 |
Maltezou, HC | 1 |
Blanc, MC; Dennetière, G; Gaillat, J; Raffin-Bru, E; Valette, M | 1 |
McAndrew, JM; Muder, RR; Risa, KJ | 1 |
Claas, EC; Gooskens, J; Jonges, M; Kroes, AM; Meijer, A; van den Broek, PJ | 1 |
Allchin, L; Booy, R; Dwyer, DE; MacIntyre, CR; Seale, H; Weston, KM; Zhu, M | 1 |
Gordon, SM | 1 |
Barr, IG; Holien, JK; Hurt, AC; Parker, MW | 1 |
Cunha, BA; Davis, M; Syed, U; Thekkel, V | 1 |
Acosta, EP; Gal, P; Jester, P; Kimberlin, DW; Wade, J; Whitley, RJ; Wimmer, J | 1 |
Abdelrahman, T; Barnes, R; Davies, E; Evans, MR; Fegan, C; Froude, S; Galiano, M; Hastings, M; Knapper, S; Lackenby, A; Litt, E; Moore, C; Price, N; Salmon, R; Temple, M | 1 |
Anderson, DJ; Chen, LF; Dailey, NJ; Deyde, VM; Duffy, J; Fleischauer, AT; Fry, AM; Greenwald, I; Gubareva, LV; Moore, ZS; Rao, AK; Sexton, DJ; Srinivasan, A; Wolfe, CR | 1 |
Bridger, NA; Bullard, JM; Coombs, JM; Crockett, ME; Embree, JE; Fanella, ST; Olekson, KL; Pinto, MA; Poliquin, PG; Van Caeseele, PG | 1 |
Buchbinder, N; Dumesnil, C; Filhon, B; Merle, V; Pinquier, D; Schneider, P; Vannier, JP | 1 |
Angeles-Garay, U; Arias-Flores, R; Gayosso Rivera, JA; Rechy-Luna, M; Terrazas Estrada, JJ; Zacate-Palacios, Y | 1 |
Felderhoff-Müser, U; Göpel, W; Härtel, C; Heitmann, F; Hoehn, T; Keller, M; Roggendorf, M; Ross, S; Stein, A | 1 |
Alves, C; Basílio, C; Castelo-Branco, S; Dias, C; Figueiredo, P; Honrado, T; Mergulhão, P; Mota, AM; Oliveira, T; Paiva, JA; Paiva, L; Roncon-Albuquerque, R; Santos, L; Sarmento, A; Silva, S; Veiga, R | 1 |
Harahousou, E; Kapetanakis, I; Kyriakou, D; Maltezou, H; Nika, A; Stripeli, F; Tsagris, V; Tsolia, M | 1 |
Carr, M; Cosgrave, M; Crowley, B; Duffy, M; Igoe, D; O'Herlihy, B; Sayers, G | 1 |
Kosaki, K; Mitamura, K; Sato, S; Shinjoh, M; Sugaya, N; Takahashi, T; Takeuchi, Y | 1 |
Harling, R; Hayward, A; Watson, JM | 1 |
Adachi, K; Annaka, M; Chimura, Y; Higuchi, H; Inamatsu, T; Ishikawa, T; Kosugi, Y; Masuda, Y; Sadamasu, K; Shibazaki, S; Shinkai, T | 1 |
Andrieu, AG; Belmin, J; Glomot, L; Jarlier, V; Paute, J | 1 |
Jarvinen, KA; McCall, BJ; Mohr, CM | 1 |
Loewen, N; Parker, R; Skowronski, D | 1 |
Farr, BM; Hall, KK; Hayden, FG; Salgado, CD | 1 |
5 review(s) available for oseltamivir and Cross Infection
Article | Year |
---|---|
Executive summary. Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiolo
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Cross Infection; Disease Management; Drug Resistance, Viral; Humans; Influenza Vaccines; Influenza, Human; Organ Transplantation; Oseltamivir; Postoperative Complications; Superinfection; Zanamivir | 2013 |
Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Cross Infection; Diagnosis, Differential; Disease Management; Drug Resistance, Viral; HN Protein; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Inpatients; Kidney Diseases; Organ Transplantation; Oseltamivir; Outpatients; Pneumonia; Postoperative Complications; Superinfection; Zanamivir | 2013 |
Nosocomial influenza: new concepts and practice.
Topics: Antiviral Agents; Cross Infection; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Molecular Diagnostic Techniques; Oseltamivir | 2008 |
Update on 2009 pandemic influenza A (H1N1) virus.
Topics: Aged; Antiviral Agents; Cross Infection; Disease Outbreaks; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Oseltamivir | 2009 |
Influenza in the acute hospital setting.
Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir | 2002 |
35 other study(ies) available for oseltamivir and Cross Infection
Article | Year |
---|---|
Risk factors and disease severity in Australian infants aged under 6 months hospitalised with influenza 2011-2019.
Topics: Australia; Cross Infection; Female; Hospitalization; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Prospective Studies; Risk Factors; Severity of Illness Index | 2022 |
A retrospective observational study of the treatment of a nosocomial infection caused by oseltamivir-resistant influenza virus A with baloxavir marboxil.
Topics: Cross Infection; Dibenzothiepins; Disease Outbreaks; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Morpholines; Oseltamivir; Oxazines; Pre-Exposure Prophylaxis; Pyridines; Pyridones; Retrospective Studies; Thiepins; Treatment Outcome; Triazines | 2020 |
The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in Manitoba, Canada, 2014-2015: a retrospective cohort study.
Topics: Antiviral Agents; Chemoprevention; Cross Infection; Disease Outbreaks; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Logistic Models; Long-Term Care; Manitoba; Oseltamivir; Retrospective Studies; Time Factors | 2018 |
Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.
Topics: Adult; Aged; Antiviral Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Viral; Female; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Retrospective Studies | 2013 |
The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland.
Topics: Adult; Age of Onset; Aged; Antiviral Agents; Arthritis; Cause of Death; Coinfection; Comorbidity; Cross Infection; Delayed Diagnosis; Disease Progression; Fatty Liver; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia; Poland; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Survival Rate; Young Adult | 2013 |
Impact of the 2009 influenza A (H1N1) pandemic on healthcare workers at a tertiary care center in New York City.
Topics: Adult; Aged; Algorithms; Antiviral Agents; Community-Acquired Infections; Cross Infection; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; New York City; Occupational Diseases; Occupational Exposure; Oseltamivir; Pandemics; Personnel, Hospital; Retrospective Studies; Sick Leave; Tertiary Care Centers; Young Adult | 2013 |
A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Cross Infection; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Risk Factors; Treatment Outcome; Young Adult | 2013 |
Contribution of systematic RT-PCR screening for influenza during the epidemic season.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Cross Infection; Delayed Diagnosis; Diagnosis, Differential; Disease Outbreaks; Emergency Service, Hospital; Female; Fever; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lung Diseases; Male; Middle Aged; Oseltamivir; Patients' Rooms; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Seasons; Sensitivity and Specificity | 2014 |
Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults.
Topics: Adult; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Odds Ratio; Oseltamivir; Pregnancy; Turkey; Zanamivir | 2014 |
Infection control preparedness for human infection with influenza A H7N9 in Hong Kong.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air Microbiology; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Contact Tracing; Cross Infection; Female; Health Personnel; Hong Kong; Hospitals, Teaching; Humans; Infant; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Influenza A Virus, H7N9 Subtype; Influenza, Human; Male; Middle Aged; Occupational Exposure; Oseltamivir; Polymerase Chain Reaction; Population Surveillance; Post-Exposure Prophylaxis; Respiratory Protective Devices; Young Adult | 2015 |
Prevention of nosocomial transmission of influenza A (H7N9) in Hong Kong.
Topics: Antiviral Agents; China; Cross Infection; Disease Outbreaks; Hong Kong; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Personal Protective Equipment; Post-Exposure Prophylaxis; Practice Guidelines as Topic; Public Health Practice; Surveys and Questionnaires; Travel | 2015 |
Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan.
Topics: Acids, Carbocyclic; Adolescent; Adult; Aged; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cyclopentanes; Drug Resistance, Viral; Female; Genes, Viral; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Middle Aged; Mutation; Oseltamivir; Phylogeny; Seasons; Young Adult | 2017 |
Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
Topics: Adolescent; Adult; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; Humans; Immunocompromised Host; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Retrospective Studies; Stem Cell Transplantation | 2017 |
Summer influenza outbreak in a home for the elderly: application of preventive measures.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; France; Homes for the Aged; Humans; Infection Control; Influenza A virus; Influenza, Human; Male; Nursing Homes; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Seasons | 2008 |
Influenza outbreak management on a locked behavioral health unit.
Topics: Antiviral Agents; Chemoprevention; Cross Infection; Disease Outbreaks; Humans; Infection Control; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Isolation | 2009 |
Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Viral; Enzyme Inhibitors; Female; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Molecular Sequence Data; Morbidity; Neuraminidase; Oseltamivir | 2009 |
The use of oseltamivir during an influenza B outbreak in a chronic care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Australia; Chemoprevention; Cross Infection; Disease Outbreaks; Female; Hospitals; Humans; Influenza B virus; Influenza, Human; Long-Term Care; Male; Middle Aged; Oseltamivir; Treatment Outcome | 2009 |
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
Topics: Cross Infection; Drug Resistance, Viral; Global Health; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Population Surveillance; Rimantadine; Zanamivir | 2009 |
Unusual nosocomial exposure to H1N1 influenza virus via open-chest cardiac massage.
Topics: Adult; Antiviral Agents; Chemoprevention; Cross Infection; Health Personnel; Heart Arrest; Heart Massage; Humans; Infectious Disease Transmission, Patient-to-Professional; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Occupational Exposure; Oseltamivir | 2010 |
Oseltamivir dosing for influenza infection in premature neonates.
Topics: Adult; Antiviral Agents; Cross Infection; Female; Humans; Infant, Newborn; Infant, Premature; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir | 2010 |
Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.
Topics: Adult; Aged; Amino Acid Substitution; Antiviral Agents; Cross Infection; Drug Resistance, Viral; Hemagglutinins, Viral; Hospitals; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Middle Aged; Mutation, Missense; Neuraminidase; Oseltamivir; RNA, Viral; Sequence Analysis, DNA; United Kingdom; Viral Proteins | 2011 |
Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Viral; Hospitals; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interviews as Topic; Middle Aged; North Carolina; Oseltamivir; Pandemics; Phylogeny; Retrospective Studies | 2011 |
Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infection Control; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Length of Stay; Male; Manitoba; Oseltamivir; Pandemics; Retrospective Studies; Risk Factors; Seasons | 2011 |
Pandemic A/H1N1/2009 influenza in a paediatric haematology and oncology unit: successful management of a sudden outbreak.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Contact Tracing; Cross Infection; Disease Outbreaks; France; Hematology; Hospital Units; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Medical Oncology; Oseltamivir; Pandemics; Patient Isolation; Pediatrics | 2011 |
[Clinical features and contagiousness of influenza A(H1N1) in health care workers and hospitalized patients in a Mexico City hospital].
Topics: Adult; Aged; Antiviral Agents; Comorbidity; Contact Tracing; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Hospitals, Urban; Humans; Immunocompromised Host; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inpatients; Male; Mexico; Middle Aged; Neoplasms; Occupational Diseases; Oseltamivir; Personnel, Hospital; Virulence; Zanamivir | 2011 |
Pandemic A/H1N1(2009) influenza infections in very-low-birth-weight infants--a case series from the German Neonatal Network.
Topics: Antiviral Agents; Cause of Death; Cross Infection; Diagnosis, Differential; Female; Germany; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Survival Rate | 2011 |
Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Comorbidity; Cross Infection; Extracorporeal Membrane Oxygenation; Female; Hemodynamics; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Point-of-Care Systems; Respiratory Distress Syndrome | 2012 |
Influenza A/H1N1/2009 outbreak in a neonatal intensive care unit.
Topics: Antiviral Agents; Chemoprevention; Cross Infection; Disease Outbreaks; Female; Humans; Infant, Newborn; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care, Neonatal; Male; Oseltamivir; Prospective Studies; Treatment Outcome | 2012 |
High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; Humans; Infection Control; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Ireland; Male; Middle Aged; Nursing Homes; Oseltamivir; Vaccination | 2013 |
[Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].
Topics: Acetamides; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Enzyme Inhibitors; Female; Hospital Departments; Humans; Infant; Influenza, Human; Male; Oseltamivir; Pediatrics | 2004 |
Implications of the incidence of influenza-like illness in nursing homes for influenza chemoprophylaxis: descriptive study.
Topics: Acetamides; Aged; Antiviral Agents; Cross Infection; Female; Guideline Adherence; Homes for the Aged; Humans; Incidence; Influenza, Human; Male; Nursing Homes; Oseltamivir; Practice Guidelines as Topic | 2004 |
[Control of hospital infection of influenza: administration of neuraminidase inhibitor and cohort isolation of influenza patients].
Topics: Acetamides; Aged; Antiviral Agents; Cross Infection; Disease Outbreaks; Female; Humans; Influenza, Human; Male; Neuraminidase; Oseltamivir; Patient Isolation | 2004 |
[Nosocomial influenza outbreak in a geriatrics department: Effectiveness of preventive measures].
Topics: Aged, 80 and over; Antiviral Agents; Chemoprevention; Cross Infection; Disease Outbreaks; Female; France; Hospital Units; Humans; Infection Control; Influenza Vaccines; Influenza, Human; Male; Oseltamivir | 2006 |
Observations on managing an outbreak of influenza A infection in an aged care facility.
Topics: Aged; Antiviral Agents; Cross Infection; Disease Outbreaks; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Queensland | 2007 |
Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Topics: Acetamides; Antiviral Agents; British Columbia; Cross Infection; Disease Outbreaks; Humans; Influenza B virus; Influenza, Human; Nursing Homes; Oseltamivir | 2001 |